Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing high-dose versus standard-dose rifampicin in adults with pulmonary tuberculosis to characterize pharmacokinetics and pharmacodynamics. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Rifampicin

Snippet

Sponsor: Radboud University Medical Center | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED